Tanıdır, CananTanıdır, İbrahimTuzcu, Volkan10.07.20192019-07-1010.07.20192019-07-102015Tanıdır, C., Tanıdır, İ. ve Tuzcu, V. (2015). Treatment of depression in an adolescent with cardiomyopathy and arrhythmia. Cardiology in the Young, 25(7), 1418-1420. https://dx.doi.org/10.1017/S10479511140023031047-95111467-1107https://dx.doi.org/10.1017/S1047951114002303https://hdl.handle.net/20.500.12511/2122WOS: 000361384800036PubMed ID: 25400066Patients with cardiomyopathy have a higher incidence of mood and anxiety disorders, resulting in greater probability for hospitalisation and increased risk for arrhythmia and death. We report a case of a 16-year-old boy with Danon disease, Wolff-Parkinson-White syndrome, and hypertrophic cardiomyopathy, who later developed depression and significant weight loss. The patient was successfully treated for his anxiety and depression with mirtazapine without any adverse cardiac effects.eninfo:eu-repo/semantics/embargoedAccessArrhythmiaDanon DiseaseDepressionHypertrophic CardiomyopathyMirtazapineTreatment of depression in an adolescent with cardiomyopathy and arrhythmiaArticle2571418142010.1017/S1047951114002303Q4Q3